Works matching AU Kim, Dong-Wan

Results: 220
    1

    Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study.

    Published in:
    2021
    By:
    • Park, Keunchil;
    • Jӓnne, Pasi A.;
    • Kim, Dong‐Wan;
    • Han, Ji‐Youn;
    • Wu, Ming‐Fang;
    • Lee, Jong‐Seok;
    • Kang, Jin‐Hyoung;
    • Lee, Dae Ho;
    • Cho, Byoung Chul;
    • Yu, Chong‐Jen;
    • Pang, Yong Kek;
    • Felip, Enriqueta;
    • Kim, Hyunjin;
    • Baek, Eunhye;
    • Noh, Young Su;
    • Kim, Dong-Wan;
    • Han, Ji-Youn;
    • Wu, Ming-Fang;
    • Lee, Jong-Seok;
    • Kang, Jin-Hyoung
    Publication type:
    journal article
    2
    3
    4
    5

    Toxicity of orally administered food‐grade titanium dioxide nanoparticles.

    Published in:
    Journal of Applied Toxicology, 2021, v. 41, n. 7, p. 1127, doi. 10.1002/jat.4099
    By:
    • Han, Hyoung‐Yun;
    • Yang, Mi‐Jin;
    • Yoon, Cheolho;
    • Lee, Gwang‐Hee;
    • Kim, Dong‐Wan;
    • Kim, Tae‐Won;
    • Kwak, Minjeong;
    • Heo, Min Beom;
    • Lee, Tae Geol;
    • Kim, Soojin;
    • Oh, Jung‐Hwa;
    • Lim, Hyun‐Ji;
    • Oh, Inkyung;
    • Yoon, Seokjoo;
    • Park, Eun‐Jung
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non-Small cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy.

    Published in:
    2017
    By:
    • Yu Jin Lim;
    • Ji Hyun Chang;
    • Hak-Jae Kim;
    • Keam, Bhumsuk;
    • Tae Min Kim;
    • Dong-Wan Kim;
    • Jin Chul Paeng;
    • Keon Wook Kang;
    • June-Key Chung;
    • Yoon Kyung Jeon;
    • Doo Hyun Chung;
    • Hong-Gyun Wu;
    • Lim, Yu Jin;
    • Chang, Ji Hyun;
    • Kim, Hak-Jae;
    • Kim, Tae Min;
    • Kim, Dong-Wan;
    • Paeng, Jin Chul;
    • Kang, Keon Wook;
    • Chung, June-Key
    Publication type:
    journal article
    23
    24

    Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations.

    Published in:
    2016
    By:
    • Koung Jin Suh;
    • Bhumsuk Keam;
    • Miso Kim;
    • Young Sik Park;
    • Tae Min Kim;
    • Yoon Kyung Jeon;
    • Dong-Wan Kim;
    • Doo Hyun Chung;
    • Young Whan Kim;
    • Dae Seog Heo;
    • Suh, Koung Jin;
    • Keam, Bhumsuk;
    • Kim, Miso;
    • Park, Young Sik;
    • Kim, Tae Min;
    • Jeon, Yoon Kyung;
    • Kim, Dong-Wan;
    • Chung, Doo Hyun;
    • Kim, Young Whan;
    • Heo, Dae Seog
    Publication type:
    journal article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1569, doi. 10.1007/s00432-019-02862-x
    By:
    • Schuler, Martin;
    • Tan, Eng-Huat;
    • O'Byrne, Kenneth;
    • Zhang, Li;
    • Boyer, Michael;
    • Mok, Tony;
    • Hirsh, Vera;
    • Yang, James Chih-Hsin;
    • Lee, Ki Hyeong;
    • Lu, Shun;
    • Shi, Yuankai;
    • Kim, Sang-We;
    • Laskin, Janessa;
    • Kim, Dong-Wan;
    • Arvis, Catherine Dubos;
    • Kölbeck, Karl;
    • Massey, Dan;
    • Märten, Angela;
    • Paz-Ares, Luis;
    • Park, Keunchil
    Publication type:
    Article
    37

    Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 4, p. 873, doi. 10.1007/s00432-015-2083-2
    By:
    • Ock, Chan-Young;
    • Son, Bongjun;
    • Keam, Bhumsuk;
    • Lee, Seung-Youn;
    • Moon, Jaewoo;
    • Kwak, Hwanjong;
    • Kim, Sehui;
    • Kim, Tae;
    • Jeon, Yoon;
    • Kwon, Seong;
    • Hah, J. Hun;
    • Lee, Se-Hoon;
    • Kwon, Tack-Kyun;
    • Kim, Dong-Wan;
    • Wu, Hong-Gyun;
    • Sung, Myung-Whun;
    • Heo, Dae
    Publication type:
    Article
    38
    39
    40
    41
    42

    First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2443, doi. 10.1007/s00262-023-03430-6
    By:
    • Bendell, Johanna;
    • LoRusso, Patricia;
    • Overman, Michael;
    • Noonan, Anne M.;
    • Kim, Dong-Wan;
    • Strickler, John H.;
    • Kim, Sang-We;
    • Clarke, Stephen;
    • George, Thomas J.;
    • Grimison, Peter S.;
    • Barve, Minal;
    • Amin, Manik;
    • Desai, Jayesh;
    • Wise-Draper, Trisha;
    • Eck, Steven;
    • Jiang, Yu;
    • Khan, Anis A.;
    • Wu, Yuling;
    • Martin, Philip;
    • Cooper, Zachary A.
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50